Sign Up Today and Learn More About Odyssey Therapeutics Stock
Invest in or calculate the value of your shares in Odyssey Therapeutics or other pre-IPO companies through EquityZen's platform.
Odyssey Therapeutics Stock (ODTH)
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
About Odyssey Therapeutics Stock
Founded
2021
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Odyssey Therapeutics Press Mentions
Stay in the know about the latest news on Odyssey Therapeutics
Odyssey Therapeutics Announces Formation of Scientific Advisory Board
businesswire • Sep 27, 2024
Odyssey Therapeutics Appoints Preeminent Chemist Dr. William Roush as Executive Vice President and Head of Small Molecule Research
businesswire • Aug 01, 2024
Odyssey Therapeutics discovers new RIPK2 inhibitors
bioworld • Jun 21, 2024
Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery
finance • Apr 08, 2024
Odyssey Therapeutics and Janssen Pharmaceutica enter drug discovery collaboration
bioworld • Apr 08, 2024
Odyssey Therapeutics Management
Leadership team at Odyssey Therapeutics
Founder and CEO
Gary Glick
Co-Founder and Chief Innovation Officer
David Pompliano
Join now and verify your accreditation status to gain access to:
- Odyssey Therapeutics current valuation
- Odyssey Therapeutics stock price
- Available deals in Odyssey Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Odyssey Therapeutics Stock
How to invest in Odyssey Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Odyssey Therapeutics through EquityZen funds. These investments are made available by existing Odyssey Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Odyssey Therapeutics stock?
Shareholders can sell their Odyssey Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
